Degradation of Alzheimer's ß-Amyloid Protein by Human and Rat Brain Peptidases: Involvement of Insulin-Degrading Enzyme (original) (raw)
REFERENCES
Glenner, G. G., and Wong, C. W. 1984. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 112:1131–1135. Google Scholar
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. 1985. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82:4245–4249. Google Scholar
Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 325:733–736. Google Scholar
Goldgaber, D., Leman, M. I., McBride, O. W., Saffiotti, U., and Gadjusek, D. C. 1987. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235:877–880. Google Scholar
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., and Younkin, S. G. 1992. Production of the Alzheimer amyloid β-protein by normal proteolytic processing. Science 258:126–129. Google Scholar
Haass, C., Hung, A. Y., Schlossmacher, M. G., Teplow, D. B., and Selkoe, D. J. 1993. β-amyloid peptide and a 3-kDa fragment are derived by distinct molecular mechanisms. J. Biol. Chem. 268:3021–3024. Google Scholar
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., and Schenk, D. 1992. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325–327. Google Scholar
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., and Selkoe, D. J. 1992. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359:322–325. Google Scholar
Esch, F. S., Keim, P. S., Beattie, E. C., Blacker, R. W., Culwell, A. K., Oltersdorf, T., McClure, D., and Ward, P. J. 1990. Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science 248:1122–1124. Google Scholar
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D. J. 1992. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360:672–674. Google Scholar
Cai, X., Golde, T. E., and Younkin, S. G. 1993. Release of excess amyloid-β protein from a mutant amyloid-β protein precursor. Science 259:514–516. Google Scholar
Duckworth, W. C. 1988. Insulin degradation: mechanisms, products and significance. Endocrin. Rev. 9:319–345. Google Scholar
Kurochkin, I. V., and Goto, S. 1994. Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345:33–37. Google Scholar
McDermott, J. R., and Gibson, A. M. 1995. Identification and characterization of central nervous system peptidase activities. Pages 281–295, in Smith A. I., (ed), Methods in Neurosciences, Vol 23: Peptidases and neuropeptide processing pp. 281–295. Academic Press, San Diego. Google Scholar
Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254. Google Scholar
Duckworth, W. C., Heinemann, M., and Kitabchi, A. E. 1972. Purification of insulin specific protease by affinity chromatography. Proc. Natl. Acad. Sci. USA 69:3698–3702. Google Scholar
Jarrett, J. T., Berger, E. P., and Lansburg, P. T. 1993. The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693–4697. Google Scholar
Authier, F., Rachubinski, R. A., Posner, B. I., and Bergeron, J. J. M. 1994. Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme. J. Biol. Chem. 269:3010–3016. Google Scholar
Hardy, J., and Allsop, D. 1991. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12:383–388. Google Scholar
Selkoe, D. J. 1994. Normal and abnormal biology of the β-amyloid precursor protein. Ann. Rev. Neurosci. 17:489–517. Google Scholar
Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., and Lannfelt, L. 1992. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genet. 1:345–347. Google Scholar
Axelman, K., Basun, H., Winblad, B., and Lannfelt, L. 1994. A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation. Arch. Neurol. 51:1193–1197. Google Scholar
Howell, S., Nalbantoglu, J., and Crine, P. 1995. Neutral endopeptidase can hydrolyze β-amyloid(1–40) but shows no effect on β-amyloid precursor protein metabolism. Peptides 16:647–652. Google Scholar
Roher, A. E., Kasunic, T. C., Woods, A. S., Cotter, R. J., Ball, M. J., and Fridman, R. 1994. Proteolysis of Aß peptide from Alzheimer disease brain by gelatinase A. Biochem. Biophys. Res. Commun. 205:1755–1761. Google Scholar
Marks, N., Berg, M. J., Chi, L. M., Choi, J., Durrie, R., Swistok, J., Makofske, R. C., Danho, W., and Sapirstein, V. S. 1994. Hydrolysis of amyloid precursor protein-derived peptides by cysteine proteinases and extracts of rat brain clathrin-coated vesicles. Peptides 15:175–182. Google Scholar
Norstedt, C., Näslund, J., Tjernberg, L. O., Karlström, A. R., Thyberg, J., and Terenius, L. 1994. The Alzheimer Aß peptide develops protease resistance in association with its polymerization into fibrils. J. Biol. Chem. 269:30773–30776. Google Scholar
Bush, A. L., Pettingell, W. H., Paradis, M., and Tanzi, R. E. 1994. Modulation of Aß adhesiveness and secretase site cleavage by zinc. J. Biol. Chem. 269:12152–12158. Google Scholar
McDermott, J. R., and Gibson, A. M. 1991. The processing of Alzheimer A4/ß-amyloid protein precursor: identification of a human brain metallopeptidase which cleaves-Lys-Leu-in a model peptide. Biochem. Biophys. Res. Commun. 179:1148–1154. Google Scholar
Tagawa, K., Kunishita, T., Maruyama, K., Yoshikawa, K., Kominami, E., Tsuchiya, T., Suzuki, K., Tabira, T., Sugita, H., and Ishiura, S. 1991. Alzheimer's disease amyloid β-clipping enzyme (APP secretase): identification, purification and characterization of the enzyme. Biochem. Biophys. Res. Commun. 177:377–387. Google Scholar
Skidgel, R. A., Engelbrecht, S., Johnson, A. R., and Erdös, E. G. 1984. Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides 5:769–776. Google Scholar
Kenny, A. J., Bowes, M. A., Gees, N. S., and Matsas, R. 1985. Endopeptidase 24.11: a cell surface enzyme for metabolizing regulatory peptides. Biochem. Soc. Trans. 13:293–295. Google Scholar
Barelli, H., Vincent, J.-P., and Checler, F. 1993. Rat kidney endopeptidase 24.16. Eur. J. Biochem. 211:79–80. Google Scholar
Allholter, J. A., Hsieh, C.-L., Francke, U., and Roth, R. A. 1990. Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes. Mol. Endocrinol. 4:1125–1135. Google Scholar
Baumeister, H., Müller, D., Rehbein, M., and Richter, D. 1993. The rat insulin-degrading enzyme: molecular cloning and characterization of tissue-specific transcripts. FEBS Lett. 317:250–254. Google Scholar
Kuo, W.-L., Gehm, B. D., Rosner, M. R., Li, W., and Keller, G. 1994. Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line. J. Biol. Chem. 269:22599–22606. Google Scholar
Kuo, W.-L., Gehm, B. D., and Rosner, M. R. 1991. Regulation of insulin degradation: expression of an evolutionary conserved insulin-degrading enzyme increases degradation via an intracellular pathway. Mol. Endocrinol. 5:1467–1476. Google Scholar
Yokono, K., Roth, R. A., and Baba, S. 1982. Identification of insulin degrading enzyme on the surface of cultured human lymphocytes, rat hepatoma cells and primary cultures of rat hepatocytes. Endocrinology 111:1102–1108. Google Scholar
Fleig, W. E., Hoss, G., Nother-Fleig, B., and Ditschuneit, H. 1986. Insulin binding to cultured adult hepatocytes: effects of bacitracin and chloroquine on the nature of cell associated radioactivity. Biochem. J. 237:99–104. Google Scholar
Caro, J. F., Muller, G., and Gennon, J. A. 1982. Insulin processing by liver. J. Biol. Chem. 257:8459–8466. Google Scholar
Hamel, F. G., Posner, B. I., Bergeron, J. J. M., Frank, B. H., and Duckworth, W. C. 1988. Isolation of insulin degradation products from endosomes derived from intact rat liver. J. Biol. Chem. 263:6703–6708. Google Scholar
McDermott, J. R., and Gibson, A. M. 1996. Degradation of Alzheimer's β-amyloid protein by human cathepsin D. NeuroReport, 7: (in press).
Cataldo, A. M., Barnett, J. L., Berman, S. A., Li, J., Quarless, S., Bursztajn, S., Lippa, C., and Nixon, R. A. 1995. Gene expression and cellular content of cathepsin D in human neocortex: evidence for early upregulation of the endosomal-lysosomal system in pyramidal neurons in Alzheimer disease. Neuron 14:1–20. Google Scholar
Cataldo, A. M., Paskevich, P. A., Kominami, E., and Nixon, R. A. 1991. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA. 88:10998–11002. Google Scholar
Schwagerl, A. L., Mohan, P. S., Cataldo, A. M., Vonsattel, J. P., Kowall, N. W., and Nixon, R. A. 1995. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. J. Neurochem. 64:443–446. Google Scholar
Mantle, D., Falkous, G., Ishiura, S., Perry, R. H., and Perry, E. K. 1995. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease. J. Neurol. Sci. 131:65–70. Google Scholar
Turner, A. J., Hooper, N. M., and Kenny, A. J. 1987. Metabolism of neuropeptides. Pages 211–248, in Kenny, A. J. and Turner, A. J., (eds), Mammalian Ectoenzymes. Elsevier, Amsterdam. Google Scholar
Checler, F. 1993. Neuropeptide degrading peptidases. Pages 375–417, in Parvez, S. H., Naoi, M., Nagatsu, T., and Parvez, S. (eds), Methods in Neurotransmitters and Neuropeptide Research, Elsevier, Amsterdam. Google Scholar
Perera, I. K., Candy, J. M., Håkansson, P., Oakley, A. E., Brinkmalm, G., and Sundqvist, B. U. R. 1990. UV-laser-induced desorption mass spectrometry of insulin, substance P and A4 amyloid protein fragments from synthetic fibrillary aggregates. Rapid Commun. in Mass Spectrom. 4:527–532. Google Scholar